Skip to main content
MB

MindMend Biotech

MindMend Bio develops targeted therapies for neurodegenerative diseases using advanced biotechnology techniques, including gene editing and biomarker identification. The company aims to improve patient outcomes by addressing the underlying biological mechanisms of conditions such as Alzheimer's and Parkinson's disease.

Traction 4/10
Hobbs, United States · HQ
Founded 2024810+ followers
  • Biotechnology
Updated 7 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Abigail Tubbs

Chief Technology Officer

Product

Features

  • MindMend Bio develops targeted therapies for neurodegenerative diseases using advanced biotechnology techniques, including gene editing and biomarker identification. The company aims to improve patient outcomes by addressing the underlying biological mechanisms of conditions such as Alzheimer's and Parkinson's disease.
This profile is AI-generated and may contain inaccuracies.